2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Monday, December 14, 2026
04:30 p.m. - 06:00 p.m.
MCCNO - R06-R09
Technology and Procedures, Molecular Testing, Bioinformatics, Treatment Considerations, Biological Therapies, (CAR)-T Cell Therapies, Immunotherapy, Biological Processes, Apoptosis, Genomics, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Diseases, Immunology, Myeloid Malignancies, Acute Myeloid Malignancies, Research, Fundamental Science, AML, Translational Research, Study Population, Animal Model
PAPER

986 RNA methyltransferase Nsun5 activity drives lymphopoietic priming and thymic seeding

Hyorim Jeong, MS, Kilian A Sottoriva, PhD2, Lily Kimball3, Lijian Shao Sr, MD, PhD4, Kostandin Pajcini, Associate Professor5
1 University of Illinois at Chicago, Chicago, Illinois, United States
2 University of Illinois at Chicago, Chicago, Illinois, United States
3 University of Illinois at Chicago, Chicago, Illinois, United States
4 University of Illinois at Chicago, Chicago, Illinois, United States
5 University of Illinois at Chicago, Chicago, Illinois, United States

T-cell recovery and reconstitution following hematopoietic stem cell transplantation remain inefficient, leaving patients open to opportunistic pathogens and life-threatening infections. A cellular adaptive immune system after pre-conditioning regimens relies on two factors: sufficient supply of thymic-seeding progenitors and thymic tissue regeneration. To identify novel regulators of bone marrow lymphopoiesis, we analyzed RNA sequencing of sorted common lymphoid progenitors (CLPs) from Notch1-deficient mice and identified Nsun5, which encodes a 28S ribosomal RNA methyltransferase, as a Notch-responsive gene. Consistent with a role in Notch-driven T-cell development, Nsun5 expression increased during early thymocyte differentiation and peaked near the DN3 stage.

To investigate the function of NSUN5, we generated progenitor-specific Nsun5 conditional knockout mice (Nsun5F/F Flt3-Cre+). Nsun5-deficient mice exhibited a marked reduction in thymus size and total thymocyte cellularity despite preserved total bone marrow cellularity. Analysis of hematopoietic progenitors revealed reduced LSK and CLP populations in the bone marrow, accompanied by a severe reduction in early thymic progenitors (ETPs), indicating impaired establishment of the earliest T-lineage compartment. Analysis of developmental stages further revealed a reduction in CD8 SP thymocytes as well as in peripheral tissues such as spleen and lymph nodes. In parallel, NSUN5 gain-of-function studies in lymphoid progenitors from Notch-deficient and wild-type mice are tested to determine whether NSUN5 can restore or accelerate T-cell development and enhance thymic recovery.

 Given the established role of NSUN5 in ribosomal RNA methylation, we next assessed nascent protein synthesis during thymocyte development using O-propargyl-puromycin (OPP) incorporation. Nsun5 deficiency markedly reduced OPP incorporation across developmental stages, with the greatest reduction observed in CD8 single-positive thymocytes. To determine whether these developmental defects were cell-intrinsic impairment in T-cell differentiation, hematopoietic progenitors were cultured on OP9-DLL1 stromal cells. Nsun5-deficient progenitors displayed impaired differentiation toward the T-cell lineage and reduced competitive fitness relative to wild-type controls, attributed to a lack of Myc and Lck translation as determined by defects in polysome assembly and ribosome foot printing.

Together, these findings identify NSUN5 as a previously unrecognized ribosome-associated regulator required for early T-cell development. Nsun5 loss compromises progenitor fitness, nascent protein synthesis, and T-lineage differentiation, supporting a model in which NSUN5 plays a novel role in translation-dependent control of lymphopoiesis.

Hyorim Jeong, MS: No relevant conflicts of interest to declare.